Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ex-Valeant CEO's Pay Structure May Have Increased Dangerous Risk-Taking, Study Says
Ex-Valeant CEO's Pay Structure May Have Increased Dangerous Risk-Taking, Study Says
Ex-Valeant CEO's Pay Structure May Have Increased Dangerous Risk-Taking, Study Says
Submitted by
admin
on June 8, 2016 - 3:10pm
Source:
Forbes
News Tags:
Valeant Pharmaceuticals
J. Michael Pearson
executive pay
Headline:
Ex-Valeant CEO's Pay Structure May Have Increased Dangerous Risk-Taking, Study Says
Do Not Allow Advertisers to Use My Personal information
